Back

The protective effect of bergamot polyphenolic fraction on reno-cardiac damage induced by DOCA-salt and unilateral renal artery ligation in rats

12 April 2024 (08:30 - 17:30)
Organised by: Logo
Congress Presentation Part of: Poster session 1 Basic Science, Other CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Miss Anna Rita Coppoletta

(Italy)

68 More presentations in this session

Presentation thumbnail
Stage specific effects of insulin and Wnt on cell fate decisions in human induced pluripotent stem cell-derived cardiomyocytes
Assistant Professor J. Buikema (Amsterdam, NL)
Abstract
Presentation thumbnail
Role of NLRP3 inflammasome in cardiac damage in the setting of an acute cardiorenal syndrome
Ms L. Gonzalez-Lafuente (Madrid, ES)
Abstract
Presentation thumbnail
Altered firing activity of intracardiac neurons isolated from mice carrying the Scn5a-1798insD mutation
Doctor S. Casini (Amsterdam, NL)
Abstract
Presentation thumbnail
Adeno-associated virus (AAV) 6 provides efficient gene transfer upon intramyocardial injection in vivo
Mr J. Wang (Amsterdam, NL)
Abstract
Presentation thumbnail
Cardioprotective effects of Empagliflozin in cardiac volume overload-induced by aortocaval fistula in rats
Doctor M. Sykora (Bratislava, SK)
Abstract

Access the full session

Session thumbnail
Poster session 1

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April 2024 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Renocardiac protective effects of SGLT2 inhibitor combined with angiotensin receptor blocker in salt sensitive Dahl rats
27 August 2021
thumbnail
Congress Presentation
Arthritis induced systemic inflammation aggravates murine heart failure
1 September 2025
thumbnail
Congress Presentation
Quercetin blocks senescence-related cardiorenal fibrosis induced by hypertension
1 September 2025
thumbnail
Congress Presentation
The effects of chronic cannabidiol dosing on cardiovascular parameters in primary hypertension: A summary of findings from a randomized controlled trial
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources